Triple-Negative Breast Cancer First In England As NICE Reverses Tecentriq Rejection

 
• By Neena Brizmohun
  
Macro photo of tooth wheel mechanism with FUNDING concept words
Patients with triple-negative breast cancer will be able to access Tecentriq via the NHS • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access